AbbVie Inc (ABBV)
166.18
+1.52
(+0.92%)
USD |
NYSE |
Apr 19, 13:32
AbbVie Price: 166.18 for April 19, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 18, 2024 | 164.96 | 167.44 | 164.43 | 164.66 | 4.479M |
| Apr 17, 2024 | 164.15 | 164.74 | 163.23 | 164.25 | 4.792M |
| Apr 16, 2024 | 162.18 | 163.74 | 162.08 | 162.54 | 4.882M |
| Apr 15, 2024 | 164.52 | 164.70 | 161.50 | 161.67 | 5.434M |
| Apr 12, 2024 | 164.45 | 164.45 | 160.00 | 162.28 | 7.029M |
| Apr 11, 2024 | 169.20 | 169.37 | 167.23 | 167.52 | 3.307M |
| Apr 10, 2024 | 168.59 | 169.96 | 167.36 | 169.03 | 3.232M |
| Apr 09, 2024 | 169.73 | 170.54 | 167.40 | 170.14 | 5.934M |
| Apr 08, 2024 | 169.21 | 171.97 | 168.40 | 169.80 | 4.745M |
| Apr 05, 2024 | 168.00 | 171.04 | 167.29 | 170.00 | 7.030M |
| Apr 04, 2024 | 177.65 | 177.70 | 167.45 | 167.90 | 10.54M |
| Apr 03, 2024 | 180.72 | 181.60 | 176.60 | 177.33 | 5.893M |
| Apr 02, 2024 | 179.39 | 181.03 | 178.51 | 180.69 | 4.524M |
| Apr 01, 2024 | 181.88 | 181.90 | 179.24 | 180.76 | 3.502M |
| Mar 28, 2024 | 181.00 | 182.30 | 180.30 | 182.10 | 5.419M |
| Mar 27, 2024 | 179.80 | 180.58 | 178.81 | 180.35 | 5.074M |
| Mar 26, 2024 | 179.23 | 179.77 | 178.38 | 179.19 | 4.392M |
| Mar 25, 2024 | 179.00 | 179.20 | 178.12 | 178.53 | 4.367M |
| Mar 22, 2024 | 177.23 | 178.99 | 176.78 | 178.45 | 4.084M |
| Mar 21, 2024 | 176.81 | 177.74 | 175.88 | 177.50 | 5.744M |
| Mar 20, 2024 | 179.22 | 179.23 | 175.73 | 176.27 | 7.327M |
| Mar 19, 2024 | 178.19 | 179.93 | 178.19 | 179.66 | 7.626M |
| Mar 18, 2024 | 179.01 | 179.88 | 177.56 | 178.49 | 8.569M |
| Mar 15, 2024 | 179.84 | 180.58 | 177.54 | 177.88 | 20.96M |
| Mar 14, 2024 | 180.16 | 182.04 | 178.66 | 181.20 | 6.999M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
62.98
Minimum
Aug 15 2019
182.10
Maximum
Mar 28 2024
121.03
Average
116.99
Median
Jul 21 2021
Price Benchmarks
| Amgen Inc | 267.46 |
| Gilead Sciences Inc | 66.37 |
| Immunogen Inc (DELISTED) | 31.23 |
| Johnson & Johnson | 146.94 |
| Eli Lilly and Co | 731.79 |
Price Related Metrics
| PE Ratio | 60.87 |
| PS Ratio | 5.426 |
| Price to Book Value | 28.34 |
| Price to Free Cash Flow | 13.36 |
| Earnings Yield | 1.64% |
| Market Cap | 293.55B |
| Operating PE Ratio | 21.77 |
| Normalized PE Ratio | 53.17 |